Navigation Links
Tracking the Battle Against Breast Cancer With New Market Research
Date:1/29/2013

FARMINGTON, Conn., Jan. 29, 2013 /PRNewswire-iReach/ -- Breast cancer is the most diagnosed cancer in women and is the leading cause of death among women globally. Increased public awareness and improved screening have led to earlier diagnosis, significantly improving survival rates, particularly in younger women. Unfortunately, many early breast cancer growths are not associated with pain or discomfort, and therefore are first detected as abnormalities on mammograms before patients or healthcare providers notice them.

(Logo:  http://photos.prnewswire.com/prnh/20130129/CG49640)

Global Information (GII) highlights three market research reports covering the breast cancer market, drug pipeline and partnering deal activities. The reports will help participating organizations benchmark their own developments against worldwide data, compare portfolio and therapy focus with peers, jumpstart competitive drug intelligence operations, and more.

Time is running out to register for the Molecular Med Tri-Con 2013, which will feature conference programs in the following channels: diagnostics, therapeutics, clinical, informatics, and cancer.

Molecular Med Tri-Con 2013| February 11 – 15, 2013 | San Francisco, CA

Visit https://www.giiresearch.com/conference/en/order/246560 to register today

Breast Cancer Drug Pipeline Update 2013

There are currently 351 companies plus partners who are developing 479 drugs targeting breast cancer across 247 different targets. In addition, there are 7 suspended drugs and another 185 drugs where development has been ceased.


'/>"/>

SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Precision motion tracking Thousands of cells at a time
2. Precision motion tracking - Thousands of cells at a time
3. Clinical technique sets new standard for speed in battle to prevent pandemic infection
4. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. MU researchers identify key plant immune response in fight against bacteria
7. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
8. Nanosurgery and the fight against cancer: Major breakthrough at Polytechnique Montral
9. 3M Withdraws Blackmail Claims Against Harvey Boulter From New York Court
10. Defending against chemical acts of terrorism
11. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Pipette.com has added the ... their comprehensive portfolio of Eppendorf products. , The Eppendorf ... a Centrifuge 5424/5424 R and receive the following:, ... Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)...  Derma Sciences, Inc. (Nasdaq: DSCI ), ... care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts ... the Premier, Inc. Regenerative Skin Grafting contract portfolio. ... and AMNIOMATRIX® product lines, which continue to be ...
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... for cells and tissues  ("BioLife" or the "Company"), today ... Stockholders on May 4, 2015 (the "Annual Meeting"). ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... N.J., Nov. 19 Novo Nordisk Inc.,announced today ... Sciele,Pharma, Inc. to market Prandin(R) (repaglinide). Under the ... and, upon approval by,the US Food and Drug ... repaglinide/metformin fixed dose combination tablet) to,physicians in the ...
... for dental implants in Italy is ... less than other European countries, WALTHAM, Mass., Nov. 19 ... into an important,dental implant pricing trend in Europe. The average ... than that of dental implants sold,in Germany, France, and the ...
... healthcare in rural South ... welfare of its people, NEW YORK, Nov. 16 Sharon L. ... Chairman of the Board of,the American Friends of the Phelophepa Train (AFPT). ... work of,the AFPT Board, Archbishop Desmond Tutu and Ms. Leah Tutu in ...
Cached Biology Technology:Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R) 2Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R) 3Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market 2Deloitte Chairman of the Board Sharon L. Allen Named Chairman of the American Friends of the Phelophepa Train 2
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday Season may ... Acuity Market Intelligence reports that the long anticipated floodgates ... that intensifying demand for smart phones, tablets, and wearable ... market of 2.5 billion users with nearly 4.8 billion ...
(Date:12/19/2014)... LaunchKey , the first decentralized mobile authentication and authorization ... era, today announced the close of $3 million in ... Metamorphic Ventures with participation from ENIAC Ventures, Crosslink Capital, ... has raised $4 million to date, and will use ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... of the body,s chemistry is controlled by the brain from ... recently in Developmental Cell , a team of scientists led ... exact structure of one crucial brain area in which biochemical commands ... there to the body. In the process, they discovered a surprising ...
... Seoul, S. Korea One of the most common ... targeted in a new collaborative venture between the internationally-renowned ... Korean arm of the leading global healthcare company, Sanofi-Aventis ... high throughput assay to screen IP-K,s chemical libraries for ...
... Mass., Nov. 2, 2011 VeCommerce Incorporated, a ... the recent completion of a management buyout from ... business as SimplySay, specializes in communications and speech ... services, insurance, and pari-mutuel wagering. ...
Cached Biology News:A hormone ensures its future 2Institut Pasteur Korea and Sanofi open a new research collaboration to combat HBV 2Institut Pasteur Korea and Sanofi open a new research collaboration to combat HBV 3VeCommerce Inc. Becomes SimplySay 2
... the benefits of a Hybridizer and UV Crosslinker ... , This unique, new design ... hybridization at one location , Hybridizer and ... each other , The Crosslinker is also ...
The bench-top stand comfortably holds up to 6 Finnpipette Digital single- and multichannel pipettes. The crossbars are made of a grippy material to keep the pipettes firmly in place. Individual shelf...
... Protein Phosphatase ( l-PPase) ... phosphatase with activity towards ... tyrosine residues. It is ... of the ORF221 open ...
... Analysis Note: Assays in Tris buffer, ... in the glycine buffer system. Assays in ... 5X that of the glycine buffer system. ... powder containing Tris-citrate buffer salts Preparation Unit ...
Biology Products: